Article | June 25, 2026

RABS And Retrofitting Existing Plants: The Alternative Solution To Comply With The New GMP Annex 1

Meeting GMP Annex 1 is forcing many manufacturers to rethink contamination control, especially in facilities not originally designed for sterile or low-bioburden production. Retrofitting with Restricted Access Barrier Systems (RABS) offers a practical path forward, balancing containment performance with lower cost and faster implementation than isolators. Success depends on a deep understanding of the process: identifying moving parts, airflow disruptions, manual interventions, and product pathways. Strategic design choices—from optimized ventilation to targeted air intake and CFD validation—help ensure reliable laminar flow and minimize risk. With the right expertise, retrofitting becomes a controlled, data-driven exercise rather than a disruptive overhaul, enabling compliance without unnecessary complexity.

Explore how a structured approach can streamline upgrades and strengthen process protection.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Pharmaceutical Online